Five leading research universities pledged today to do more to ensure that poor people and developing nations can get access to new drugs based on inventions coming from academic research, according to Bloomberg News. The five signers are Harvard University (which has already used licensing terms in deals to promote this “global access”) as well as the University of Pennsylvania and Boston, Brown, and Yale Universities. The push for global access comes from the campuses and from Universities Allied for Essential Medicines, which has also been urging Congress and research universities to oppose a measure in legislation to overhaul the health-care system that would give drug companies 12 years of exclusive rights to certain new kinds of drugs.
|
Previous Republican Lawmaker Accuses Education Department of Lobbying Violation |
Next Student Reporter Held Responsible for Trespassing at James Madison U. |
5 Universities to Use Licensing to Provide Cheaper Drugs to Poor and to Developing World
November 9, 2009, 1:38 pm
Confirm Your Email Address
You must confirm the email address associated with your account to use this Chronicle feature.
If you have already confirmed your account, try refreshing your browser.
E-mail a Friend

